CoreValve holds size advantage for U.S. TAVR

When the Food and Drug Administration in January granted marketing approval to a second transcatheter aortic valve replacement system for inoperable patients with aortic stenosis, the CoreValve...

Field of Interest: Cardiology
Type: News Item

FDA approves dapagliflozin for type 2 diabetes

Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, has been approved for the treatment of type 2 diabetes with a requirement that the manufacturer conduct postmarketing studies that address...

Field of Interest: Endocrinology
Type: News Item

‘JNC 8’ guideline follows convoluted endgame

UPDATED Jan. 4, 2014 The federally funded program to produce a set of U.S. guidelines for hypertension management, a process more than 5 years in the making, came to an unusual end on...

Field of Interest: Cardiology
Type: News Item

Antipsychotics boosted CVD events in elderly

DALLAS – Elderly patients who started treatment with an antipsychotic drug had a substantially increased risk for a major adverse cardiovascular disease event, especially during the first month on...

Field of Interest: Cardiology
Type: News Item

Statin reduces MI risk in ischemic heart failure

DALLAS – Rosuvastatin appears to reduce the risk of acute myocardial infarction in patients with ischemic heart failure, according to a meta-analysis of two landmark statin trials. This finding is...

Field of Interest: Cardiology
Type: News Item

Energy drinks amp up heart contractility

CHICAGO – Consumption of an energy drink containing caffeine and taurine slightly, but significantly, altered left ventricular contractility in healthy volunteers, while consuming the same amount of...

Field of Interest: Cardiology
Type: News Item

Abrupt increase noted in LVAD thrombosis

An abrupt and unexpected increase in pump thrombosis has occurred since March 2011 in patients with advanced heart failure who received the HeartMate II left ventricular assist device, according to a...

Field of Interest: Cardiology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness